Nexentis Technologies Inc. (NXTS)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch NXTS
See up to 3 months of NXTS. The 7-day demo opens the 1M and 3M ranges and puts NXTS on your watchlist.
Start 7-day demoLatest NXTS insider trades
Eun Young LeeOpen-market sale$172- Ronen Rosenbloom - DirectorOpen-market purchase50,000 sh
- Asaf Itzhaik - DirectorGrant or award14,795 sh
- Lital Barda - OfficerGrant or award51,000 sh
- David Palach - OfficerGrant or award101,549 sh
- Israel Yakov Berenstein - DirectorGrant or award19,375 sh
- Amitay Weiss - DirectorGrant or award101,549 sh
- Shlomo Zakai - OfficerGrant or award51,000 sh
About Nexentis Technologies Inc. (NXTS)
Nexentis Technologies Inc. is an SEC registrant, filing under CIK 0001789192, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site. A registration statement was filed on 13 July 2026. No offering has priced.
NXTS Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 9 | 392,813 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
NXTS insider transactions (Form 4)
2121 Form 4 filings on record, the earliest from Dec 26, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Asaf Itzhaik - Director | Grant or award | Restricted Shares of Common Stock | 14,795 footnote F1 | $0.00 | - | |
| ||||||
| Lital Barda - Officer | Grant or award | Restricted Shares of Common Stock | 51,000 footnote F1 | $0.00 | - | |
| ||||||
| David Palach - Officer | Grant or award | Restricted Shares of Common Stock | 101,549 footnote F1 | $0.00 | - | |
| ||||||
| Israel Yakov Berenstein - Director | Grant or award | Restricted Shares of Common Stock | 19,375 footnote F1 | $0.00 | - | |
| ||||||
| Amitay Weiss - Director | Grant or award | Restricted Shares of Common Stock | 101,549 footnote F1 | $0.00 | - | |
| ||||||
| Shlomo Zakai - Officer | Grant or award | Restricted Shares of Common Stock | 51,000 footnote F1 | $0.00 | - | |
| ||||||
| Ronen Rosenbloom - Director | Grant or award | Restricted Shares of Common Stock | 19,375 footnote F1 | $0.00 | - | |
| ||||||
| Eliahou Arbib - Director | Grant or award | Restricted Shares of Common Stock | 19,375 footnote F1 | $0.00 | - | |
| ||||||
| Liat Sidi - Director | Grant or award | Restricted Shares of Common Stock | 14,795 footnote F1 | $0.00 | - | |
| ||||||
| Eun Young Lee | Open-market sale | Common Stock, par value $0.0001 per share | 127 | $1.36 footnote F1 | $172 | |
| ||||||
| Shlomo Zakai - Officer | Grant or award | Restricted Shares of Common Stock | 50,000 footnote F1 | $0.00 | - | |
| ||||||
| Lital Barda - Officer | Grant or award | Restricted Shares of Common Stock | 50,000 footnote F1 | $0.00 | - | |
| ||||||
| Amitay Weiss - Director | Grant or award | Restricted Shares of Common Stock | 116,286 footnote F1 | $0.00 | - | |
| ||||||
| David Palach - Officer | Grant or award | Restricted Shares of Common Stock | 100,000 footnote F1 | $0.00 | - | |
| ||||||
| Liat Sidi - Director | Grant or award | Restricted Shares of Common Stock | 50,000 | $0.00 | - | |
| Ronen Rosenbloom - Director | Open-market purchase | Restricted Shares of Common Stock | 50,000 | $0.00 | - | |
| Udi Ovadia Kalifi - Director | Grant or award | Restricted Shares of Common Stock | 50,000 | $0.00 | - | |
| Israel Yakov Berenstein - Director | Grant or award | Restricted Shares of Common Stock | 50,000 | $0.00 | - | |
| Eliahou Arbib - Director | Grant or award | Restricted Shares of Common Stock | 50,000 | $0.00 | - | |
| Amitay Weiss - Director | Grant or award | Restricted Shares of Common Stock | 350,000 | $0.00 | - | |
| Asaf Itzhaik - Director | Grant or award | Restricted Shares of Common Stock | 50,000 | $0.00 | - | |
Item 3.02, 5.02
Item 1.01, 9.01
Item 3.01
Item 4.01, 9.01
Item 1.01, 3.02, 9.01
NXTS insider trading FAQ
What is the latest insider trade for NXTS?
Nexentis Technologies Inc. (NXTS) had 9 insider filings in the last 90 days, with the most recent on 22 October 2026. The full record for NXTS runs to 21 Form 4 filings, the earliest from 26 December 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying NXTS stock?
No insider purchases of NXTS were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling NXTS stock?
No insider sales of NXTS were filed in the last 90 days. 1 sale is on record for this company.
Where can I see NXTS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects NXTS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Asaf Itzhaik view on EDGAR
- - Lital Barda view on EDGAR
- - David Palach view on EDGAR
- - Israel Yakov Berenstein view on EDGAR
- - Amitay Weiss view on EDGAR
- - Shlomo Zakai view on EDGAR
- - Ronen Rosenbloom view on EDGAR
- - Eliahou Arbib view on EDGAR
- - Liat Sidi view on EDGAR
- - Eun Young Lee view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where NXTS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow NXTS with a 7-day demo
- NXTS on your watchlist
- Every NXTS Form 4 filing on record
- Up to 3 months of NXTS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.